Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.740
-0.030 (-1.69%)
At close: Feb 11, 2026, 4:00 PM EST
1.720
-0.020 (-1.15%)
After-hours: Feb 11, 2026, 6:16 PM EST

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
48372334
Market Cap Growth
-46.39%132.51%-47.96%-71.05%-32.20%-28.18%
Enterprise Value
-22-11-14-834
Last Close Price
1.725.923.1310.8441.60101.20
PS Ratio
0.451.600.781.343.404.24
PB Ratio
0.431.300.270.320.741.19
P/TBV Ratio
0.691.310.270.320.751.26
EV/Sales Ratio
-0.34---4.24
Debt / Equity Ratio
-0.030.080.100.110.33
Asset Turnover
0.430.300.180.140.150.20
Inventory Turnover
2.693.292.001.062.183.16
Quick Ratio
2.942.113.385.205.964.29
Current Ratio
3.673.614.176.037.025.02
Return on Equity (ROE)
-64.65%-45.62%-31.72%-14.62%-54.01%-32.68%
Return on Assets (ROA)
-31.48%-28.06%-15.04%-12.38%-33.30%-26.92%
Return on Capital Employed (ROCE)
-95.30%-68.10%-36.30%-29.20%-62.50%-42.00%
Earnings Yield
-135.03%-87.10%-402.29%-230.24%-63.54%-13.68%
FCF Yield
-162.21%-119.34%-440.21%-210.37%-116.48%-95.66%
Buyback Yield / Dilution
-0.28%-10.22%-106.37%-12.66%-113.68%-56.51%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q